China Universal Asset Management Co., Ltd. Keros Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,217 shares of KROS stock, worth $435,545. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,217
Previous 4,239
70.25%
Holding current value
$435,545
Previous $193,000
117.1%
% of portfolio
0.05%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding KROS
# of Institutions
174Shares Held
30.3MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$152 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$115 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$112 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$92 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$91.4 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.55B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...